Suchergebnisse - "Ji, Longshan"

PubPharm (8)

1

Bushen Formula promotes the decrease of HBsAg levels in patients with CHB by regulating Tfh cells and B-cell subsets

enthalten in: Journal of ethnopharmacology | 2024

von Ji, L. | Wei, J. | Zhang, R. | +7

2

Integrating bulk and single-cell RNA sequencing data to establish necroptosis-related lncRNA risk model and analyze the immune microenvironment in hepatocellular carcinoma

enthalten in: Heliyon | 2023

von Zhang, R. | Li, Q. | Yu, X. | +10

3

Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD : A promising drug Potentilla discolor Bunge

enthalten in: Acta pharmaceutica Sinica. B | 2022

von Ji, L. | Li, Q. | He, Y. | +8

4

Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma

enthalten in: Journal for immunotherapy of cancer | 2022

von Yu, Z. | Li, Y. | Li, Y. | +13

5

Determination of HMGB1 in hepatitis B virus-related acute-on-chronic liver failure patients with acute kidney injury : Early prediction and prognostic implications

enthalten in: Frontiers in pharmacology | 2022

von Liu, Y. | Yuan, W. | Fang, M. | +10

6

Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma

enthalten in: Journal of hepatocellular carcinoma | 2022

von Li, Y. | Li, Y. | Zhang, J. | +6

7

Application of atractylenolide III in preparation of medicine for treating non-alcoholic fatty liver disease

enthalten in: Europäisches Patentamt | 2021

von LI MAN | GAO YUEQIU | SUN XUEHUA | +7

8

Role of follicular helper T cells in development and progression of liver diseases

in: Linchuang Gandanbing Zazhi | 2016

von JI Longshan | SUN Xuehua | ZHOU Zhenhua

1
[1]